• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of molecular mechanism and treatment for abnormal ryanodine receptor in patients with malignant hyperthermia and lethal arrhythmia

Research Project

Project/Area Number 18591706
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Anesthesiology/Resuscitation studies
Research InstitutionYamaguchi University

Principal Investigator

KOBAYASHI Shigeki  Yamaguchi University, Hospital, Assistant Professor (90397993)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Takeshi  Yamaguchi University, Graduate Scheel of Medicine, Assistant Professor (50363122)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥3,940,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥540,000)
Fiscal Year 2007: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2006: ¥1,600,000 (Direct Cost: ¥1,600,000)
Keywordsinternal medicine / heart failure / ryanodine receptor / dantrolene / arrhythmia
Research Abstract

The N-terminal (1-600) and central (2000-2500) domains of the ryanodine receptor (RyR), harbor many mutations associated with malignant hyperthermia (MH), catecholaminergic polymorphic ventricular tachycardia (CPVT), and arrhythmogenic right ventricular cardiomyopathy type 2. There is strong evidence to suggest that inter-domain interaction between these regions plays an important role in the mechanism of channel regulation. Recently we reported that dantrolene, a specific drug for the treatment of MH, prevented abnormal Ca^<2+> leak by the correction of the defective inter-domain interaction between N-terminal and central domains within MU RyRI. Here, we examined the effect of dantrolene on the Ca^<2+> release function of RyR2 in human CPVT-associated RyR2^<R24745/+> knock-in (KI) mice model.
To identify the dantrolene-binding region we screened several recombinant fragments (-600 amino acid residues) corresponding to various regions covering the area from the N-terminus to residue 275 … More 0, which include the aforementioned mutable domains. Dantrolene was found to specifically bind to the domain 601-620 of RyR2 using a quartz crystal microbalance technique (a highly sensitive mass-measuring technique). ECG was monitored in KI mice (n=6) and wild-type (WT) mice (n=6), before and after injection of epinephrine (1.0 mg/kg) or exercise by treadmill. In KI mice bi-directional ventricular tachycardia (VT) was easily induced after injection of epinephrine or exercise, but not in WT mice. In K1 mice pretreated with dantrolene for 7 days, number of premature ventricular contractions at rest significantly decreased, and VT was not induced by injection of epinephrine or exercise. In cardiomyocytes from KI mice, Ca^<2+> spark (SpF; s^<-1>・100μm^<-1>:15.8±0.6, p<0.01) and delayed afterdepolarization-mediated Ca^<2+> transient (DAD-CaT) were frequently seen after addition of isoproterenol, compared to those from WT mice (SpF: 0.8±0.1). Both SpF and DAD-CaT seen in KI mice were inhibited by 1.0 μM dantrolene (SpF: 1.5±0.2, p<0.01).
In cardiomyocytes from KI mice, Ca' spark (SpF ; s1900prif 15.8±0.6, p<0.01) and delayed afterdepolarization-mediated Ca' transient(DAD-CaT) were frequently seen after addition of isoproterenol, compared to those from WT mice (SpF : 0.8±0.1). Both SpF and DAD-CaT seen in KI mice were inhibited by 1.0 p.M dantrolene (SpF : I.5±0.2, p<0.01). n conclusion, dantrolene, by interacting with N-terminal mutable domain, seems to correct the hypersensitized channel gating caused by RyR2 mutation, thereby inhibiting diastolic Ca^<2+> sparks, DAD, and then lethal arrhythmia. Less

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (17 results)

All 2008 2007 2006

All Journal Article (9 results) (of which Peer Reviewed: 5 results) Presentation (8 results)

  • [Journal Article] Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts2008

    • Author(s)
      Takeshi Yamamoto
    • Journal Title

      Circulation 117

      Pages: 762-772

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts2008

    • Author(s)
      Yamamoto, T, Yano, M, Xu, X, Uchinoumi, H, Tateishi, H, Mochizuki, M, Oda, T, Kobayashi, S, Ikemoto, N, Matsuzaki, M
    • Journal Title

      Circulation 117

      Pages: 762-72

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts2008

    • Author(s)
      山本 健
    • Journal Title

      Circulation 117

      Pages: 762-772

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca^<2+> leak via stabilization of ryanodine receptor in heart failure2007

    • Author(s)
      Mamoru Mochizuki
    • Journal Title

      J Am Coll Cardiol 49

      Pages: 1722-1732

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca^<2+>leak via stabilization of ryanodine receptor in heart failure2007

    • Author(s)
      Mamoru, Mochizuki, Masafumi, Yano, Tetsuro, Oda, Hiroki, Tateishi, Shigeki Kobayashi, Takeshi, Yamamoto, Yasuhiro, Ikeda, Tomoko, Ohkusa, Noriaki, Ikemoto, Masunori, Matsuzaki
    • Journal Title

      J Am Coll Cardiol 49

      Pages: 1722-1732

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca^<2+> leak via stabilization of ryanodine receptor in heart failure2007

    • Author(s)
      望月 守
    • Journal Title

      J Am Coll Cardiol 49

      Pages: 1722-1732

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 心不全におけるリアノジン受容体機能異常2007

    • Author(s)
      小林 茂樹
    • Journal Title

      細胞工学, 秀潤社 26

      Pages: 365-370

    • Related Report
      2007 Annual Research Report
  • [Journal Article] Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure.2007

    • Author(s)
      望月守
    • Journal Title

      J Am Coll Cardiol 49

      Pages: 1722-32

    • Related Report
      2006 Annual Research Report
  • [Journal Article] ATl receptor antagonist restores cardiac ryanodine receptor function, rendering isoproterenol-induced failing heart less susceptible to Ca2+ -leak induced by oxidative stress.2006

    • Author(s)
      Takahiro Tokuhisa
    • Journal Title

      Circulation Journal 70

      Pages: 777-786

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Presentation] Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic Polymorphic Ventricular Tachycardia: Insights from a RyR2 R2474S/+ Knock-in Mouse Model2008

    • Author(s)
      Shigeki Kobayashi
    • Organizer
      The 72nd Annual Scientific Meeting of the Japanese Circulation Society
    • Place of Presentation
      Fukuoka, Japan
    • Year and Date
      2008-03-28
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Dantrolene,a therapeutic agent for malignant hyperthermia,inhibits cathecholaminergic polymorphic ventricular tachycardia:Insights from a RyR2 R2474S/+knock-in mouse model2008

    • Author(s)
      小林 茂樹
    • Organizer
      第72回日本循環器学会総会・学術集会
    • Place of Presentation
      福岡
    • Year and Date
      2008-03-28
    • Related Report
      2007 Annual Research Report
  • [Presentation] Correction of Defective Inter-Domain Interactions within Ryanodine Recepter by Dantrolene May be a Potent Therapeutic Strategy against Lethal Arrhythmia2007

    • Author(s)
      Shigeki Kobayashi
    • Organizer
      The 71st Annual Scientific Meeting of the Japanese Circulation Society
    • Place of Presentation
      Kobe, Japan
    • Year and Date
      2007-03-16
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Dantrolene, A Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic Polymorphic Ventricular Tachycardia: Insights from a RyR2R2474S/+Knock-in Mouse Model2007

    • Author(s)
      Shigeki Kobayashi
    • Organizer
      Scientific Sessions 2007 of American Heart Association
    • Place of Presentation
      Orland, USA
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Stabilization of Ryanodine Receptor by Dantrolene may be a Potent Therapeutic Strategy Against Lethal Arrhythmia2006

    • Author(s)
      Shigeki Kobayashi
    • Organizer
      The 10th Annual Scientific Meeting of the Japanese Heart Failure Soiety
    • Place of Presentation
      Tokyo, Japan
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Correction of Defective Inter-Domain Interacitons within Ryanodine Recepter by Dantrolene may be a Potent Therapeutic Strategy Against Lethal Arrhythmia2006

    • Author(s)
      Shigeki Kobayashi
    • Organizer
      Scientific Sessions 2006 of American Heart Association
    • Place of Presentation
      Chicago, USA
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Correction of Defective Inter-Domain Interacitons within Ryanodine Recepter by Dantrolene may be a Potent Therapeutic Strategy Against Lethal Arrhythmia2006

    • Author(s)
      Shigeki, Kobayashi, Masafumi, Yano, Takeshi, Yamamoto, Xu, Xiaojuan, Makoto, Ono, Hitoshi, Uchinoumi, Hiroki, Tateishi, Mamoru, Mochizuki, Toshiyuki, Noma
    • Organizer
      Scientific Sessions 2006 of American Heart Association
    • Place of Presentation
      Chicago
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Dantrolene, A Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic Polymorphic Ventricular Tachycardia : Insights from a RyR2R2474S/+Knock-in Mouse Model2006

    • Author(s)
      Shigeki, Kobayashi, Masafumi, Yano, Hitoshi, Uchinoumi, Xiaojuan, Xu, Makoto, Ohno, Hiroki, Tateishi, Takeshi, Yamamoto, Masunori, Matsuzaki
    • Organizer
      Scientific Sessions 2006 of American Heart Association
    • Place of Presentation
      Orland
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi